abstract |
(57) [Summary]nThe present invention relates to the determination of authentic HCV genomic RNA sequences, construction of infectious HCV DNA clones, and the use of the clones or derivatives thereof in therapeutic, vaccine and diagnostic applications. Furthermore, the invention relates to HCV vectors, for example gene vaccines for gene therapy. |